FRE.DE
Fresenius SE & Co. KGaA N
XETRAEUREQUITY
Healthcare
DELAYED
Last price
46.60
▲ 0.38 (0.83%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
46.38
Prev close
46.22
Day high
46.71
Day low
45.91
Volume
776.91K
Market cap
—
P/E (TTM)
16.82
52W range
35.11 – 52.96
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
152.07M
Total on file
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-1.02%
+0.3%
1M
+8.75%
+5.0%
3M
+23.31%
+20.2%
6M
-9.90%
-21.0%
YTD
-4.86%
-17.1%
1Y
-2.29%
-22.3%
3Y
+57.49%
-16.7%
5Y
+11.81%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value$37.09B
Revenue (TTM)$23.28B
Gross profit$5.90B
EBITDA$3.04B
Net income$1.56B
EPS (TTM)$2.77
Free cash flow$1.71B
Total cash$1.28B
Total debt$11.42B
Book value / share$34.98
Shares outstanding—
Float410.56M
Short % of float—
Dividend yield2.25%
Beta (5Y)0.83
Valuation & profitability ratios
Trailing P/E16.82
Forward P/E11.78
PEG ratio0.90
Price / sales—
Price / book1.33
EV / revenue1.59
EV / EBITDA12.20
Gross margin25.35%
Operating margin10.63%
Profit margin6.54%
Return on equity8.29%
Return on assets3.43%
Debt / equity55.98
Current ratio1.28
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $22.87B | $21.95B | $21.07B | $21.53B | +4.2% |
| Operating revenue | $22.87B | $21.95B | $21.07B | $21.53B | +4.2% |
| Cost of revenue | $17.18B | $16.32B | $16.10B | $16.13B | +5.3% |
| Gross profit | $5.69B | $5.64B | $4.97B | $5.40B | +1.0% |
| Research & development | $633.00M | $641.00M | $661.00M | $639.00M | -1.2% |
| Selling, general & admin | $2.88B | $2.89B | $3.03B | $3.09B | -0.2% |
| Total operating expense | $3.51B | $3.56B | $3.79B | $3.59B | -1.5% |
| Operating income | $2.18B | $2.07B | $1.18B | $1.81B | +5.2% |
| Net interest income | -$320.00M | -$429.00M | -$398.00M | -$215.00M | +25.4% |
| Pre-tax income | $2.19B | $1.68B | $773.00M | $1.60B | +30.1% |
| Tax provision | $582.00M | $530.00M | $485.00M | $375.00M | +9.8% |
| Net income | $1.26B | $471.00M | -$594.00M | $1.37B | +168.4% |
| Net income to common | $1.26B | $471.00M | -$594.00M | $1.37B | +168.4% |
| Basic EPS | 2.24 | 0.84 | -1.05 | 2.44 | +166.7% |
| Diluted EPS | 2.24 | 0.84 | -1.05 | 2.44 | +166.7% |
| EBIT | $2.63B | $2.23B | $1.29B | $1.94B | +17.9% |
| EBITDA | $3.75B | $3.47B | $2.69B | $3.10B | +8.1% |
| Basic shares | 563.24M | 563.24M | 563.24M | 561.26M | 0.0% |
| Diluted shares | 563.24M | 563.24M | 563.24M | 561.26M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $1.31B | $2.05B | $2.29B | $2.57B | -36.1% |
| Cash & short-term investments | $1.31B | $2.05B | $2.29B | $2.57B | -36.1% |
| Accounts receivable | $3.56B | $3.50B | $3.67B | $7.16B | +1.7% |
| Inventory | $2.61B | $2.57B | $2.52B | $4.83B | +1.5% |
| Total current assets | $11.03B | $11.45B | $12.52B | $18.28B | -3.7% |
| Property, plant & equipment | $9.72B | $9.89B | $10.78B | $18.84B | -1.7% |
| Goodwill & intangibles | $16.72B | $17.51B | $17.62B | $35.83B | -4.5% |
| Total assets | $41.40B | $43.55B | $45.28B | $76.40B | -4.9% |
| Total current liabilities | $8.38B | $9.01B | $9.33B | $13.66B | -6.9% |
| Current debt | $1.30B | $2.60B | $2.38B | $2.19B | -49.9% |
| Long-term debt | $9.22B | $9.48B | $11.46B | $18.99B | -2.7% |
| Total debt | $11.93B | $13.58B | $15.83B | $27.76B | -12.1% |
| Total liabilities | $21.63B | $23.26B | $25.63B | $44.18B | -7.0% |
| Shareholder equity | $19.10B | $19.54B | $19.00B | $20.41B | -2.2% |
| Working capital | $2.64B | $2.44B | $3.19B | $4.62B | +8.5% |
| Net tangible assets | $2.39B | $2.04B | $1.38B | -$15.41B | +17.3% |
| Shares issued | 563.24M | 563.24M | 563.24M | 563.24M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.61B | $1.15B | $288.00M | $1.22B | — | +39.4% |
| Depreciation & amortisation | $1.12B | $1.24B | $1.40B | $1.16B | — | -9.6% |
| Change in working capital | $267.00M | $79.00M | $399.00M | -$257.00M | — | +238.0% |
| Operating cash flow | $2.57B | $2.45B | $4.46B | $4.20B | — | +5.2% |
| Capital expenditure | -$1.50B | -$1.06B | -$1.29B | -$1.19B | — | -41.2% |
| Investing cash flow | -$815.00M | -$510.00M | -$3.19B | -$2.61B | — | -59.8% |
| Share buybacks | — | — | — | — | $0 | — |
| Dividends paid | -$684.00M | — | -$551.00M | -$403.00M | -$1.07B | — |
| Financing cash flow | -$2.42B | -$2.18B | -$1.38B | -$1.60B | — | -11.0% |
| Free cash flow | $1.08B | $1.39B | $3.17B | $3.00B | — | -22.4% |
| End cash position | $1.58B | $2.28B | $2.56B | $2.75B | — | -30.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $5.95B | $5.82B | $6.16B | — | $5.65B | $5.71B | +2.2% |
| Operating revenue | $5.95B | $5.82B | $6.16B | — | $5.65B | $5.71B | +2.2% |
| Cost of revenue | $4.39B | $4.28B | $4.63B | — | $4.19B | $4.29B | +2.6% |
| Gross profit | $1.55B | $1.53B | $1.52B | — | $1.46B | $1.41B | +1.0% |
| Research & development | $167.00M | $163.00M | $170.00M | — | $164.00M | $140.00M | +2.5% |
| Selling, general & admin | $760.00M | $743.00M | $824.00M | — | $741.00M | $644.00M | +2.3% |
| Total operating expense | $918.00M | $933.00M | $1.06B | — | $899.00M | $725.00M | -1.6% |
| Operating income | $632.00M | $601.00M | $468.40M | — | $562.00M | $689.00M | +5.2% |
| Net interest income | -$80.00M | -$58.00M | -$66.00M | — | -$107.00M | -$93.00M | -37.9% |
| Pre-tax income | $535.00M | $577.00M | $607.00M | — | $493.00M | $614.00M | -7.3% |
| Tax provision | $136.00M | $132.00M | $180.00M | — | $147.00M | $141.00M | +3.0% |
| Net income | $382.00M | $435.00M | $361.00M | — | $330.00M | $229.00M | -12.2% |
| Net income to common | $382.00M | $435.00M | $361.00M | — | $330.00M | $229.00M | -12.2% |
| Basic EPS | 0.68 | 0.77 | — | — | 0.58 | 0.41 | -11.7% |
| Diluted EPS | 0.68 | 0.77 | — | — | 0.58 | 0.41 | -11.7% |
| EBIT | $632.00M | $601.00M | $920.00M | — | $562.00M | $689.00M | +5.2% |
| EBITDA | $902.00M | $874.00M | $1.23B | $740.00M | $830.00M | — | +3.2% |
| Basic shares | 561.76M | 563.24M | — | — | 568.97M | 563.24M | -0.3% |
| Diluted shares | 561.76M | 563.24M | — | — | 568.97M | 563.24M | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.28B | $2.06B | $1.31B | $1.23B | $2.39B | -37.9% |
| Cash & short-term investments | $1.41B | $3.95B | $1.31B | $1.39B | $2.53B | -64.2% |
| Accounts receivable | $4.36B | $3.96B | $3.56B | $3.80B | $3.75B | +10.1% |
| Inventory | $2.77B | $2.73B | $2.61B | $2.59B | $2.64B | +1.6% |
| Total current assets | $11.61B | $12.07B | $11.03B | $10.88B | $11.91B | -3.8% |
| Property, plant & equipment | $9.78B | $9.73B | $9.72B | $9.63B | $9.77B | +0.5% |
| Goodwill & intangibles | $16.75B | $16.76B | $16.72B | $16.83B | $17.25B | -0.1% |
| Total assets | $41.84B | $42.37B | $41.40B | $41.32B | $43.21B | -1.2% |
| Total current liabilities | $9.07B | $9.54B | $8.38B | $8.30B | $8.33B | -4.9% |
| Current debt | $1.69B | $2.19B | $1.30B | $2.09B | $2.06B | -22.9% |
| Long-term debt | $8.33B | $8.31B | $9.22B | $9.31B | $10.09B | +0.2% |
| Total debt | $11.42B | $11.90B | $11.93B | $12.85B | $13.63B | -4.1% |
| Total liabilities | $21.45B | $21.91B | $21.63B | $22.38B | $23.14B | -2.1% |
| Shareholder equity | $19.70B | $19.78B | $19.10B | $18.28B | $19.41B | -0.4% |
| Working capital | $2.54B | $2.53B | $2.64B | $2.58B | $3.58B | +0.5% |
| Net tangible assets | $2.95B | $3.02B | $2.39B | $1.45B | $2.16B | -2.3% |
| Shares issued | 563.24M | 563.24M | 563.24M | 563.24M | 563.24M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $398.00M | — | — | $360.00M | $346.00M | $473.00M | — |
| Depreciation & amortisation | $270.00M | $273.00M | $314.00M | $274.00M | $268.00M | — | -1.1% |
| Change in working capital | -$327.00M | -$298.00M | $778.00M | $171.00M | -$139.00M | — | -9.7% |
| Operating cash flow | $344.00M | $389.00M | $1.34B | — | $418.00M | $56.00M | -11.6% |
| Capital expenditure | -$241.00M | -$196.00M | -$725.00M | -$335.00M | -$234.00M | — | -23.0% |
| Investing cash flow | $41.00M | $29.00M | -$433.00M | — | -$167.00M | $59.00M | +41.4% |
| Dividends paid | — | — | $0 | — | -$560.00M | -$96.00M | — |
| Financing cash flow | -$1.17B | $45.00M | -$1.71B | — | -$1.40B | $26.00M | -2,708.9% |
| Free cash flow | $103.00M | $193.00M | $619.00M | $421.00M | $184.00M | — | -46.6% |
| End cash position | $1.28B | $2.06B | $1.58B | — | $1.23B | $2.39B | -37.9% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.89 | 0.83 | -6.7% |
| Mar 2026 | 0.87 | 0.99 | +13.9% |
| Dec 2025 | 0.90 | 0.96 | +6.7% |
| Sep 2025 | 0.77 | 0.82 | +5.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.81 | 4 | $5.79B | +5.6% |
| Next quarter | 0.96 | 4 | $6.34B | +6.3% |
| Current year | 3.71 | 14 | $23.76B | +3.9% |
| Next year | 3.95 | 14 | $24.98B | +5.1% |
Analyst targets & ownership
Mean target$55.59
High target$63.50
Low target$50.00
Implied upside19.28%
Analyst count14
ConsensusSTRONG BUY
Strong buy / Buy5 / 8
Hold1
Sell / Strong sell0 / 0
Held by insiders27.00%
Held by institutions43.95%
Institutions holding537
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
46.77
-0.36% from price
SMA 20
45.98
+1.34% from price
SMA 50
43.18
+7.93% from price
SMA 100
41.70
+11.76% from price
SMA 200
44.95
+3.67% from price
EMA 12
46.38
+0.47% from price
EMA 26
45.33
+2.80% from price
EMA 50
43.95
+6.02% from price
RSI (14)
63.4
Neutral
MACD (12,26,9)
1.05
Hist -0.17
ATR (14)
1.04
2.24% of price
Realised vol 30D
23.1%
Annualised
Bollinger upper
48.19
20, 2σ
Bollinger lower
43.78
20, 2σ
50 / 200 cross
Death
43.18 vs 44.95
Trend bias
Above 200
+3.67%
Risk profile
Beta vs SPY
0.06
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
23.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-32.0%
Peak to trough
Max drawdown 5Y
-57.0%
Peak to trough
ATR 14
1.04
2.24% of price
Beta (reported)
0.83
5Y monthly, from filing
Dividends & splits
Forward rate$1.05 / yr
Forward yield2.25%
5-year avg yield1.15%
Payout ratio37.91%
Ex-dividend dateMay 25, 2026
Next pay date—
Last split3:1
Split dateAug 4, 2014
Headlines
Her Advisor Said Wait Until 70. At 66, She Chose Time to Enjoy Social Security Over an 8%-a-Year Raise.
24/7 Wall St. · 13m ago
Walmart's $200 military smartwatch with a handy flashlight and 'unbelievable battery' is now $27
TheStreet · 15m ago
The 30-Year Treasury Now Out-Yields Dividend Stocks by 2.2 Points. History Says What Followed the Last Time.
Motley Fool · 17m ago
World No. 3 Pegula beats defending champ Swiatek to reach Cincy final
AFP · 18m ago
Top analyst sees trouble looming for SpaceX stock
TheStreet · 18m ago
IndyCars zip among iconic Washington landmarks ahead of Freedom 250
AFP · 26m ago
He Sold Nothing in the 2022 Crash. He Swapped Into a Similar Fund for a Week, Booked $90,000 of Losses, and Hasn’t Paid Capital-Gains Tax Since.
24/7 Wall St. · 31m ago
Judge rules Keene ICE detainee unlawfully held without bond hearing
New Hampshire Union Leader, Manchester · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.